Speakers

Ellen Vieux

Senior Research Scientist

C4 Therapeutics

Jennifer Johnston

Chief Executive Officer

NysnoBio

Katie Digianantonio

Senior Research Scientist

Arvinas

Sandra Kumper

Investigator

GSK

Dan Robbins

Associate Director, Medicinal Chemistry

Nurix Therapeutics

Jennifer Venable

Senior Scientific Director

The Janssen Pharmaceutical Companies of Johnson & Johnson

Radosław Nowak

Senior Scientist, Cancer Biology

Dana-Farber Cancer Institute

Sharon Shechter

Director of Platform Integration

Roivant Sciences

Hakryul Jo

Associate Director, Platform Biology

Kymera Therapeutics

Matt Clifton

Director Structural & Biophysical Chemistry

Novartis institutes for Biomedical Research

Ryan Potts

Head of Induced Proximity Platform

Amgen

Satpal Virdee

MRC Investigator & Professor of Chemical Biology, MRC Protein Phosphorylation & Ubiquitylation Unit

University of Dundee

Benjamin Ruprecht

Director of Translational Proteomics

Roivant Sciences

Matthieu Schapira

Principal Investigator, Structural Genomics Consortium

University of Toronto

Monica Rodrigo

Senior Scientist – Safety Innovation & PROTAC safety

AstraZeneca

Smaranda Bodea

Associate Principal Scientist, Chemical Biology

Merck Research Laboratories

Gary Kleiger

Associate Professor

University of Nevada, Las Vegas

George Burslem

Assistant Professor

University of Pennsylvania

Richard Huang

Senior Principal Scientist & Group Leader

Bristol-Myers Squibb

Wei Zhang

Assistant Professor

University of Guelph

Corey Strickland

Vice President Molecular Technology

Proteovant

Luca Busino

Assistant Professor in Cancer Biology

University of Pennsylvania

Sarath Ramachandran

Postdoctoral Scientist

University of Dundee

Wu Du

Senior Vice President

Hinova Pharmaceuticals

Michael Rape

Investigator, HHMI; Professor; Dr. K. Peter Hirth Chair of Cancer Biology

HHMI/UC Berkeley

Qianhe Zhou

Principal Scientist

Foghorn Therapeutics